Ketamine in Psychiatry – A Review.
Ketamine for the Treatment of Depression – Another Review.
Serial Infusions of Low-dose Ketamine for Major Depression.
Ketamine for Treatment-resistant Unipolar Depression.
Replication of Ketamineâ€™s Antidepressant Efficacy in Bipolar Depression.
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-resistant Depression.
Ketamine and the Next Generation of Antidepressants with a Rapid Onset of Action.
Signaling Pathways Underlying the Rapid Antidepressant Actions of Ketamine.
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
Rapid Response with Ketamine on Suicidal Cognition in Resistant Depression.
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.
Intravenous Ketamine for Treatment-resistant Major Depressive Disorder.
Ketamine as a New Treatment for Depression: A Review of its Efficacy and Adverse Effects.
Maintenance Ketamine Treatment Produces Long-term Recovery from Depression.
Ketamine Infussions as a Treatment for Depression.Â
Ketamine as a fast acting antidepressant: current knowledge and open questions.
Safety and Efficacy of Repeated-dose Intravenous Ketamine for Treatment-Resistant Depression.
Rapid and Longer-term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-resistant Major Depression.
Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression
Ketamine for People with Severe Depression.
A Sceptical View of Ketamine for Depression.
Another Sceptical View of Ketamine as an Antidepressant.
Ketamine Shows Significant Benefit in People with Treatment-resistant Depression.
Clinical Experience Using Intranasal Ketamine in the Treatment of Pediatric Bipolar Disorder/Fear of Harm Phenotype.
Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting.
How Ketamine Reduces Depression.
Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine.
A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression.
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-blind, Placebo-controlled Study.
Psychiatric Safety of Ketamine in Psychopharmacology Research.
Ketamine as a Treatment for PTSD.Â
Ketamine May Offer Rapid Relief From OCD Symptoms.
National Public Radio Reports of Ketanine as an Antidepressant.
New York Times Reports on the Antidepressant Use of Ketamine.
Scientific American Reports on Ketamine
Time Magazine Reports on Ketamine as a Rapidly Acting Antidepressant.